ArticleInflammopharmacology2024

Empagliflozin attenuates intestinal inflammation through suppression of nitric oxide synthesis and myeloperoxidase activity in in vitro and in vivo models of colitis.

Adam Makaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.